Lucas Elliott Haldeman, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 111 Ironwood Ct, Denver, PA 17517 Phone: 717-940-9262 |
News Archive
Biostar Pharmaceuticals, Inc. ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced that the Chinese Military Drug Administration has granted clearance to begin clinical trials on the Company's new drug application, the Zushima Analgesic Aerosol Spray.
"Recently I attended the Africa Braintrust 2012 forum entitled 'Africa Rising: A Continent of Opportunity,' hosted by U.S. Rep. Karen Bass (D-Calif.) and the Congressional Black Caucus (CBC) as part of their Annual Legislative Conference, in Washington, D.C.," human rights activist Ivanley Noisette writes in the Huffington Post's "World" blog.
ResourcingPoint announces that demand for clinical research professional placement has doubled in the last two months. An increase in clinical activity across the industry, coupled with a strategic expansion of the ResourcingPoint database of professional staff, has enabled significant clinical outsourcing growth for the company. A variety of different companies, from emerging device to large pharma and CROs, rely on ResourcingPoint for their contracting needs.
US Oncology, Inc., the nation's premier oncology services company supporting the nation's largest network including more than 1,300 oncologists and more than 10,000 clinicians and cancer experts to advance cancer care in America, was honored on Feb. 6, by Texas Governor Rick Perry at the Texas vs. the Nation All-Star Football Challenge in El Paso, Texas. US Oncology was honored as an inaugural inductee to the Governor's Business Hall of Fame along with Baker Hughes, Bell Helicopter, and Texas Instruments.
Life Technologies has completed a multi-year license and supply agreement with Quest Diagnostics, the world's leading provider of diagnostic information services, that gives Quest rights to develop molecular tests on the Ion Torrent next-generation sequencing platform. Under the agreement, Quest may use the platform and related consumables to independently develop new tests for numerous areas of their business.
› Verified 6 days ago